BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Phase II
ARCA biopharma Announces Screening Of First Patient In Phase 2B/3 Clinical Trial Evaluating Gencaro In Atrial Fibrillation 4/17/2014  More...
Islet Sciences Announces Positive 12-Week Phase 2 Clinical Results For SGLT2 Inhibitor Remogliflozin Etabonate 4/17/2014  More...
Galapagos NV (GLPG.BR) Release: GSK2586184 Met Primary Endpoint In Phase 2a Psoriasis Study 4/17/2014  More...
Nuvilex Could Obtain FDA Accelerated Approval After Phase 2b Clinical Trial 4/17/2014  More...
VentiRx Pharmaceuticals, Inc. Announces The Completion Of Patient Enrollment In Randomized, Placebo-Controlled Phase 2 Trial Of VTX-2337 In Combination With Pegylated-Liposomal Doxorubicin In Platinum-Resistant Ovarian Cancer 4/17/2014  More...
Akebia Therapeutics, Inc. (AKBA) Announces Completion Of Enrollment In Its Phase 2b Clinical Study Of AKB-6548 4/15/2014  More...
Theravance, Inc. (THRX) Announces Initiation Of Phase 2b Study With TD-4208, An Investigational LAMA For The Treatment Of COPD 4/15/2014  More...
Final Data From The Phase 2 COSMOS Study Of Janssen Research & Development's Once-Daily Simeprevir In Combination With Sofosbuvir Presented At The International Liver Congress™ 2014 Of The European Association For The Study Of The Liver (EASL) 4/14/2014  More...
Lexicon Pharmaceuticals, Inc. (LXRX)'s LX4211 Achieves Positive Results In Type 1 Diabetes Clinical Trial 4/14/2014  More...
Cytos Biotechnology AG's Asthma Drug CYT003 Flunks Pivotal Phase 2b Study 4/14/2014  More...
Repros Therapeutics Inc. (RPRX) Fully Enrolls First Of Two Previously Announced Head To Head Studies Of Androxal® Versus The Leading Topical Testosterone Gel 4/14/2014  More...
GlycoMimetics, Inc. (GLYC) Announces Presentation Of Data On Rivipansel (GMI-1070) In Combination With Current FDA-Approved Treatment For Sickle Cell Disease 4/14/2014  More...
Merck & Co., Inc. (MRK)’s Investigational Chronic Hepatitis C Combination Therapy MK-5172/MK-8742 Demonstrates Antiviral Activity In Hard-To-Cure Patients With HCV Genotype 1 Infection 4/11/2014  More...
FDA Orders Halozyme Therapeutics, Inc. (HALO) To Halt Pancreatic Cancer Study 4/11/2014  More...
Beware Gilead Sciences, Inc. (GILD), Merck & Co., Inc. (MRK)'s Hepatitis C Combo Pill Impresses In Phase 2 Trial 4/11/2014  More...
San Diego's Celladon Corporation Grabs FDA's “Breakthrough Therapy” Status for Gene Therapy 4/11/2014  More...
GenKyoTex S.A. 's GKT137831 Found To Reverse Fibrosis And Improve Survival In A Model Of Persistent Lung Fibrosis 4/10/2014  More...
Gilead Sciences, Inc. (GILD) Announces Phase 2 Results For Two Investigational All-Oral Sofosbuvir-Based Regimens For The Treatment Of Chronic Hepatitis C 4/10/2014  More...
BioLineRx Ltd. Announces Investigator-Initiated Study For Novel Chronic Myeloid Leukemia Treatment 4/10/2014  More...
Alcobra (ADHD) Submits Protocol To FDA For Phase 2b Clinical Study Of Metadoxine Extended Release (MDX) In The Treatment Of Fragile X Syndrome 4/10/2014  More...
Seattle's Juno Therapeutics Pauses Trial After Patient Deaths 4/10/2014  More...
Nuvilex Engages Virusure To Establish Cell Banks For Phase 2b Clinical Trials In Pancreatic Cancer 4/10/2014  More...
Idenix Pharmaceuticals, Inc. (IDIX)'s "Good" News Shows Hep C Drug Market Increasingly Murky For Investors 4/9/2014  More...
Puma Biotechnology (PBYI) Plummets On Disappointing Breast Cancer Drug Results 4/9/2014  More...
Adocia Reports Positive Results From Phase 2a Clinical Study Of Ultra-Fast Acting Biochaperone® Lispro 4/9/2014  More...
Aastrom Biosciences, Inc. (ASTM) Reports Data and Safety Monitoring Board Recommendation to Continue ixCELL-DCM Clinical Trial 4/9/2014  More...
Keryx Biopharmaceuticals (KERX) Announces Zerenex™ (Ferric Citrate Coordination Complex) Phase 2 Results In Non-Dialysis Dependent Chronic Kidney Disease Selected As A Late Breaking Oral Presentation At The Upcoming National Kidney Foundation 2014 Spring Clinical Meeting 4/9/2014  More...
Viralytics Ltd (VLA.AX) Release: Positive Interim Phase 2 Trial Results For CAVATAK™, Novel Cancer Immunotherapy 4/8/2014  More...
Pfizer Inc. (PFE) Continues Its Streak, Phase 2 Breast Cancer Results Wows Investors And Researchers 4/8/2014  More...
NOXXON Pharma AG Release: Anti-Hepcidin Spiegelmer® Lexaptepid Pegol Increases Hemoglobin In Subset Of Anemic Patients In Pilot Phase 2a Study 4/8/2014  More...
Helix Biopharma (CC:HBP) Initiates Enrollment For Eighth Cohort In Polish Phase I/II Clinical Study Of Its Lung Cancer Drug Candidate L-DOS47 4/8/2014  More...
Kadmon Corporation Announces The Initiation Of KD025 Phase 2 Program In Psoriasis 4/8/2014  More...
Mologen AG (MOLGF.PK): DSLIM® Shows Superior Immunoactivation Capabilities 4/8/2014  More...
OncoSec Medical Inc. To Relaunch Phase 2 Cutaneous T-Cell Lymphoma Study At Key Centers Of Excellence 4/7/2014  More...
Ambit Biosciences Announces Initiation Of Phase 2 Cohort In MD Anderson Cancer Center Sponsored Study Of Quizartinib In AML And High Risk MDS 4/7/2014  More...
Research Expands Understanding Of Biomarker For Biothera Cancer Immunotherapy Imprime PGG 4/7/2014  More...
Lion Biotechnologies, Inc.' Lead Program With National Cancer Institute Demonstrates Positive Results In Patients With Stage 4 Metastatic Melanoma 4/7/2014  More...
NOXXON Pharma AG Presents Positive Results From Emapticap Pegol Phase 2a Diabetic Nephropathy Study 4/4/2014  More...
Halozyme Therapeutics, Inc. (HALO) Tanks As Enrollment In Phase 2 Pancreatic Cancer Study Is Halted; Stock Down -27.26% At 5:20PM ET (April 4, 2014) 4/4/2014  More...
Rumor: Will Pfizer Inc. (PFE) Unveil A Breast Cancer Blockbuster At American Association for Cancer Research? 4/4/2014  More...
Alnylam Pharmaceuticals (ALNY) Receives Positive Opinion For Orphan Drug Designation In The European Union For ALN-Ttrsc, A Subcutaneously Delivered Rnai Therapeutic For The Treatment Of Transthyretin-Mediated Amyloidosis (ATTR) 4/2/2014  More...
FDA Grants IND Approval For Phase 2a Clinical Trial Using CardioCell’s Itmsc Therapy To Treat Dilated Chronic Heart Failure 4/2/2014  More...
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Shows Off Positive Phase 2 Alirocumab Data 4/2/2014  More...
Arrowhead Research Corporation (ARWR) Completes Enrollment Of First Cohort In Phase 2a Trial Of Chronic Hepatitis B Candidate ARC-520 4/1/2014  More...
Edimer Pharmaceuticals Presents Update On Phase 2 Clinical Trial Of EDI200 At International Gathering Of Ectodermal Dysplasia Patient Foundations 4/1/2014  More...
PRANA Biotechnology (PRAN) Tanks As Lead Drug Fails Alzheimer's Study 4/1/2014  More...
Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd. (RIG2.F) Tout Positive Phase 2b Bipolar Depression Data 3/31/2014  More...
Cellceutix (CTIX) Reports 20 Percent Enrollment Completed In Phase 2b Trial Of Brilacidin As Short-Course Therapy For ABSSSI 3/31/2014  More...
Published Analysis Confirms Positive Results From Auris Medical AG's Phase 2b Study With AM-101 In Treatment Of Acute Inner Ear Tinnitus 3/31/2014  More...
Immunomedics, Inc. (IMMU) To Provide Clinical Trial Updates On Solid-Tumor Antibody-Drug Conjugates At Cancer Conference 3/31/2014  More...
Idera Pharmaceuticals, Inc. (IDRA)'s IMO-8400 Safe, Well Tolerated In Phase 2 Skin Disease Study 3/28/2014  More...
Pfizer Inc. (PFE)'s Experimental Anti-Cholesterol Drug Bococizumab Meets Main Study Goals 3/28/2014  More...
Kadmon Corporation Presents Results At The 9th International Congress On Autoimmunity Demonstrating The Effects Of KD025 On Immune Homeostasis 3/28/2014  More...
Portola Pharmaceuticals, Inc. Initiates Phase 2 Study Of Andexanet Alfa, Potential First-In-Class Factor Xa Inhibitor Reversal Agent, And Factor Xa Inhibitor Edoxaban 3/27/2014  More...
Novartis AG (NVS)'s Rare Lung Cancer Drug Ceritinib Shows Positive Response In Study 3/27/2014  More...
Insmed Incorporated (INSM) Dealt Another Setback As Lung Infection Drug Fails Mid-Stage Trial 3/27/2014  More...
Genocea Biosciences’s Therapeutic Vaccine For Herpes Simplex-2 Infection Shows Highly Significant Reductions In Clinical Symptoms At 6 Months 3/25/2014  More...
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Introduction Of The New Lot Of Lintuzumab Into The Clinic 3/25/2014  More...
Ariad Pharmaceuticals, Inc. (ARIA) Announces Initiation Of Pivotal Phase 2 ALTA Trial Of AP26113 In Patients With Non-Small Cell Lung Cancer 3/24/2014  More...
Merck & Co., Inc. (MRK) To Present New Data For Investigational Hepatitis C Treatments MK-5172 And MK-8742 At EASL Annual Meeting/The International Liver Congress™ 2014 3/24/2014  More...
Arrowhead Research Corporation (ARWR) Begins Dosing In Phase 2a Trial Of RNAi Therapeutic ARC-520 In Chronic Hepatitis B Patients 3/24/2014  More...
Kamada Ltd. (KMDA.TA) Announces Initiation Of A Phase 2 U.S. Clinical Trial Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency 3/24/2014  More...
Provectus Pharmaceuticals Inc. Submits Application To FDA To Receive Breakthrough Therapy Designation For PV-10 For Treatment Of Melanoma 3/24/2014  More...
Cellceutix (CTIX) To Initiate Psoriasis Clinical Trial 3/24/2014  More...
Endocyte, Inc. (ECYT) Doubles After Drug Shown To Slow Lung Cancer In Phase 2b Study 3/24/2014  More...
Immune Response BioPharma Announces NeuroVax Granted Fast Track FDA Designation For SPMS 3/21/2014  More...
Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd. (RIG2.F) Shows Off Positive Phase 2b Data For Cariprazine To Treat Depression 3/21/2014  More...
Antisense Therapeutics Limited (ANP.AX) Release: ATL1103 Acromegaly Phase 2 Trial Recruitment Completed 3/21/2014  More...
Synta Pharmaceuticals (SNTA) Announces Positive Interim Results From The ENCHANT-1 Trial Of Ganetespib In Metastatic Breast Cancer At The 9th European Breast Cancer Conference 3/20/2014  More...
Cortice Biosciences Announces Enrollment Of A Phase 2 Trial Evaluating TPI 287 Plus Avastin® For Treatment Of Glioblastoma Previously Treated With Anti-Angiogenic Therapy 3/20/2014  More...
Pfizer Inc. (PFE)'s Meningitis Vaccine Wins Breakthrough Status From The FDA 3/20/2014  More...
Bionomics Limited (BNO.AX) Sinks As Renal Cancer Drug Fails Key Phase 2 Test 3/19/2014  More...
Novan Therapeutics Announces Positive Phase 2 Results For Novel Acne Treatment 3/19/2014  More...
Heat Biologics Submits Revised Protocol To FDA For Phase 2 Clinical Study Of HS-110 For The Treatment Of Non-Small Cell Lung Cancer 3/19/2014  More...
ProSensa Holding N.V. (RNA) Announces 48-Week Data From A U.S. Phase 2 Placebo-Controlled Study Of Drisapersen In 51 DMD Boys 3/18/2014  More...
Ironwood Pharmaceuticals (IRWD) Initiates Phase 2 Clinical Study Of IW-3718 In Refractory Gastroesophageal Reflux Disease 3/18/2014  More...
Acceleron Pharma And Celgene Corporation (CELG) Announce Interim Clinical Data For Sotatercept In Patients With End Stage Renal Disease On Hemodialysis At The 2014 National Kidney Foundation Spring Clinical Meeting 3/18/2014  More...
Ipsen (IPN.PA): Dysport Incontinence Treatment Phase 2a Trial Positive 3/18/2014  More...
First Patient Enrolled In GenSpera G-202 Phase 2 Glioblastoma Trial 3/18/2014  More...
Pharma Two B Ltd. Commences Phase 2b Study Of Fixed Dose Combination Therapy “P2B001” For Parkinson’s Disease 3/18/2014  More...
Asthma Leader GlaxoSmithKline (GSK) Faces Competition From Roche (RHHBY), AstraZeneca PLC (AZN), Sanofi (France) (SAN.PA), And Teva Pharmaceutical Industries Limited (TEVA) 3/18/2014  More...
Edison Pharmaceuticals, Inc. Announces Initiation Of EPI-743 Pearson Syndrome Clinical Trial 3/17/2014  More...
Chimerix, Inc. (CMRX) Issues Statement Thanking The FDA For Collaboration In Developing Protocol To Treat Patients With Life-Threatening Adenovirus Infection 3/17/2014  More...
Theracos, Inc. Reports Positive Outcomes From A 96-Week Phase 2 Study Of THR1442, A Highly Specific SGLT2 Inhibitor, For The Treatment Of Type 2 Diabetes 3/17/2014  More...
FDA Grants Fast Track Status To Edison Pharmaceuticals, Inc.' EPI-743 For Friedreich's Ataxia 3/17/2014  More...
Can-Fite BioPharma (CFBI): Phase II Study Protocol To Treat Patients With Advanced Liver Cancer With CF102 Has Been Approved By The IRB In Israel 3/17/2014  More...
Bowing to Public Outrage, Chimerix, Inc. (CMRX) To Give Drug To Dying Boy 3/14/2014  More...
Achillion Pharmaceuticals, Inc. (ACHN) Announces Oral Presentations Given At APASL 2014 Detailing Clinical Activity Of ACH-3102, Second-Generation NS5A Inhibitor, Against Genotype 1b HCV 3/14/2014  More...
Cornerstone Pharmaceuticals, Inc. Lead Compound CPI-613 Demonstrates Ability To Disrupt Growth Of Cancer Cells 3/13/2014  More...
Provectus Pharmaceuticals Inc. Melanoma Version Of PV-10 Completes Phase 2 And Is Prepping For BTD 3/13/2014  More...
Slumpy OXiGENE (OXGN) Soars On Ovarian Cancer Drug Results 3/13/2014  More...
La Jolla Pharmaceutical Company (LJPC) Soars As Kidney Drug Is Effective In Phase 2 Study 3/13/2014  More...
Thousands Beg Chimerix, Inc. (CMRX) To Give Medication To Dying Boy 3/13/2014  More...
Viamet Pharmaceuticals Reports Positive Interim Results Of Phase 2 Interdigital Tinea Pedis Study Of VT-1161 3/12/2014  More...
Senesco Technologies, Inc. (SNT) Opens Two New Clinical Trial Sites And Initiates Treatment Of The First Patient In South Africa 3/12/2014  More...
BG Medicine (BGMD) Welcomes La Jolla Pharmaceutical Company (LJPC)'s Announcement Of Positive Top-Line Results Of Phase 2 Clinical Trial Of Novel Pharmaceutical Compound Targeting Galectin-3 In Chronic Kidney Disease 3/12/2014  More...
OncoSec Medical Inc. To Evaluate Increased Dose Frequency Of ImmunoPulse In Ongoing Phase II Melanoma Trial 3/12/2014  More...
Neovacs SA Announces Positive IDSMB Review Of The Phase 2b Study Of TNF-Kinoid In Rheumatoid Arthritis 3/12/2014  More...
Ultragenyx Pharmaceuticals Announces First Patient Enrolled In Phase 2 Study Of Triheptanoin In Glucose Transporter Type-1 Deficiency Syndrome 3/11/2014  More...
Omeros Corporation (OMER) Announces Positive OMS721 Data In Serum From Patients With aHUS 3/10/2014  More...
Inotek Pharmaceuticals Corporation Initiates Phase 2 Study With Trabodenoson In Combination With Latanoprost For Patients With Glaucoma Or Ocular Hypertension 3/10/2014  More...
BioLineRx Ltd. Completes Dose Escalation Stage Of Phase 1/2 Study For Novel Celiac Treatment 3/10/2014  More...
ALK-Abello A/S’s Partner For Japan Reports Positive Trial Results For House Dust Mite SLIT-Tablet 3/10/2014  More...
Cellceutix (CTIX) Reports 14 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Patients Treated In Phase 2b Clinical Trial 3/10/2014  More...
Edison Pharmaceuticals, Inc. Announces Initiation Of EPI-743 Phase 2B/3 Leigh Syndrome Clinical Trial With Dainippon Sumitomo Pharma Co., Ltd. In Japan 3/10/2014  More...
Berkeley's XOMA Corporation (XOMA) To Stop Testing Drug As Arthritis Treatment, Shares Plunge 3/6/2014  More...
Merck & Co., Inc. (MRK)'s Investigational Hepatitis C Drugs Work In HIV Co-Infected Patients In Phase 2 Study 3/6/2014  More...
Omeros Corporation (OMER) Touts Positive Data From Phase 2a Schizophrenia Drug Test 3/6/2014  More...
Roche (RHHBY) Drug Cuts Asthma Attacks, Improves Lung Function In Phase 2b Study 3/6/2014  More...
iCo Therapeutics Inc. Announces Final Eight Month Patient Visit In Phase 2 iDEAL Study 3/5/2014  More...
New Published Paper Shows Efficacy Of Lpath, Inc.'s Anti-LPA Antibody, Lpathomab, In Traumatic Brain Injury Models 3/5/2014  More...
XOMA Corporation (XOMA)’s Investigational HIV Therapy, Doravirine (MK-1439), Demonstrates Antiviral Activity In Phase 2B Study Of Treatment-Naïve Adults 3/5/2014  More...
Merck & Co., Inc. (MRK)'s Investigational HIV Therapy, Doravirine (MK-1439), Demonstrates Antiviral Activity In Phase 2B Study Of Treatment-Naïve Adults 3/5/2014  More...
Merck & Co., Inc. (MRK)'s Dust Mite Allergy Drug Reduces Symptoms In Phase 2b Study 3/5/2014  More...
Argos Therapeutics, Inc. (ARGS) Presents New Data From Clinical Research For AGS-004 Patient-Specific Immunotherapy In Treatment Of HIV 3/5/2014  More...
Medivir AB (MVRBF) Release: SVR12 Results From A Phase 2a Study Evaluating Simeprevir And Daclatasvir In Hepatitis C Patients Of Genotype 1 Have Been Presented 3/5/2014  More...
Oxygen Biotherapeutics, Inc. (OXBT) Rockets As FDA Lifts Hold On Brain Injury Drug Oxycyte 3/4/2014  More...
Galapagos NV (GLPG.BR), GlaxoSmithKline (GSK) Anti-Inflammatory Drug Pact Hits A Roadblock 3/4/2014  More...
D-Pharm Ltd. Reports The Successful Interim Analysis Of Its Phase 2 Clinical Study Of THR-18 In Acute Stroke Patients Treated With The Thrombolytic Drug tPA 3/4/2014  More...
Cellectar, Inc. Announces Initiation Of Phase 2 Imaging Trial With I-124-CLR1404 In Patients With Newly Diagnosed Or Recurrent Glioblastoma 3/4/2014  More...
Celladon Corporation Completes Enrollment Of CUPID 2 Trial For Advanced Heart Failure 3/4/2014  More...
Boston Therapeutics, Inc. To Initiate A Phase II Clinical Study Of BTI-320 In U.S. 3/4/2014  More...
Kamada Ltd. (KMDA.TA) Completes Enrollment In U.S. Pivotal Clinical Trial With Kamrab As A Post-Exposure Treatment For Rabies 3/4/2014  More...
Genticel Reaches An Important Milestone By Launching Its Phase II Trial In Women Infected With High-Risk HPV Before The Appearance Of High Grade Cervical Lesions 3/4/2014  More...
Atopix Shows Off Positive Phase 2b Results For Once Daily OC459 In Asthma 3/3/2014  More...
Arrowhead Research Corporation (ARWR) Receives Regulatory Approval To Begin Phase 2a Trial Of Chronic Hepatitis B Candidate ARC-520 3/3/2014  More...
Conatus Pharmaceuticals Inc. Extends Liver Disease Reach With Phase 2 Nafld/Nash Trial 3/3/2014  More...
FDA Grants "Orphan Drug" Designation For Genervon’s Breakthrough Multi-Target ALS Bio-Drug GM604 3/3/2014  More...
FDA Grants Fast Track Designation To Naurex Inc.'s Rapid-Acting Novel Antidepressant GLYX-13 3/3/2014  More...
Heat Biologics Commences Dosing Of First Patient In Phase 1/2 Study Of Novel Cancer Immunotherapy Product Candidate HS-410 For The Treatment Of Bladder Cancer 3/3/2014  More...
S1 BioPharma (Formerly Known As S1 Pharmaceuticals, Inc.) Prepares To Initiate Phase 2a Clinical Trial For Low Male Sexual Desire 3/3/2014  More...
GW Pharmaceuticals Receives Orphan Drug Designation By FDA For Epidiolex® In The Treatment Of Lennox-Gastaut Syndrome 2/28/2014  More...
Provectus Pharmaceuticals Inc. Melanoma Version Of PV-10 Completes Phase 2 And Is Prepping For BTD 2/28/2014  More...
Phase 2b Results Of Anergis' Lead Compound Allert To Be Presented At 2014 American Academy of Dermatology Annual Meeting In San Diego 2/27/2014  More...
Anacor Pharmaceuticals, Inc. (ANAC) Announces Successful Completion of End-of-Phase 2 Meeting With FDA For The Treatment Of Mild-to-Moderate Atopic Dermatitis With AN2728 2/27/2014  More...
Provectus Pharmaceuticals Inc. Melanoma Version Of PV-10 Completes Phase 2 And Is Prepping For BTD 2/27/2014  More...
Generex Biotechnology Corporation (GNBT) Announces Publication Of Biomarker Studies Related To The Antigen Express Novel Immunotherapeutic AE37 In Prostate Cancer Patients 2/27/2014  More...
Allergen Research Corporation Initiates Phase 2b Clinical Trial For Peanut Allergy Oral Immunotherapy (OIT) 2/27/2014  More...
ImmunoCellular Therapeutics, Ltd (IMUC) Receives Orphan Drug Status For ICT-107 In Glioblastoma In The European Union 2/26/2014  More...
Altheus Therapeutics Completes Treatment Portion Of ZA201, A Phase 2 Trial Of Zoenasa For Ulcerative Colitis 2/26/2014  More...
Cellceutix (CTIX) Enrolls First Patients In Phase 2b ABSSSI Clinical Trial 2/26/2014  More...
Isis Pharmaceuticals, Inc. (ISIS) Touts Positive Phase 2 Spinal Muscular Atrophy Study Data 2/25/2014  More...
Hyperion Therapeutics Announces The Publication Of Phase 2 Results Of Glycerol Phenylbutyrate (GPB) For The Treatment Of Hepatic Encephalopathy In Hepatology 2/25/2014  More...
Aerie Pharmaceuticals, Inc. (AERI) Announces Study Results Supporting Additional Mechanism Of Action For Lead Glaucoma Drug Candidate AR-13324 2/25/2014  More...
TRANSGENE (ENX:TNG) Announces Plans For A Phase 1b/2 Trial With Pexa-Vec In Advanced Solid Tumors 2/25/2014  More...
Synchroneuron Announces First Patient Dosed In Phase 2 Tardive Dyskinesia Clinical Trial 2/25/2014  More...
Biothera Presents Phase 2 Data To International Association For The Study Of Lung Cancer 2/24/2014  More...
Raptor Pharmaceutical Inc. (RPTP) Surges As Huntington's Drug Meets Study Endpoints 2/21/2014  More...
La Jolla Pharmaceutical Company (LJPC) Announces Final Dosing In Phase 2 Clinical Trial Of GCS-100 In Chronic Kidney Disease 2/21/2014  More...
OrthoTrophix Initiated Phase 2 Clinical Trial Of A New Cartilage Repair Therapeutic For Knee Osteoarthritis And Closed Series A Financing 2/21/2014  More...
Novartis AG (NVS)'s Experimental Skin Cancer Drug Meets Primary Endpoint In Pivotal Phase 2 Trial 2/21/2014  More...
Antares Pharma, Inc. (ATRS) Announces Positive Results From The VIBEX Quickshot Pharmacokinetic Study In Testosterone Deficient Men 2/20/2014  More...
ViroXis Corporation Achieves Key Clinical Milestones 2/20/2014  More...
Viamet Pharmaceuticals Reports Positive Interim Results Of Phase 2 Study Of VT-1161 2/19/2014  More...
Omeros Corporation (OMER) Announces Enrollment In Second Phase 2 Clinical Trial With OMS824 2/19/2014  More...
Helix Biopharma (CC:HBP) Initiates Enrollment For Seventh Cohort In Polish Phase I/II Clinical Study Of Its Lung Cancer Drug Candidate L-DOS47 2/19/2014  More...
PRANA Biotechnology (PRAN) Soars As Brain Disorder Drug Succeeds In Phase 2 Trial; Stock Up +39.31% At Market Close (February 18, 2014) 2/19/2014  More...
Sound Pharmaceuticals, Inc. Submits Positive Phase 2 Clinical Trial Data On SPI-1005 For The Prevention And Treatment Of Sensorineural Hearing Loss 2/18/2014  More...
Galapagos NV (GLPG.BR) Completes Patient Recruitment In Proof Of Concept Study With GLPG0974 In Ulcerative Colitis 2/18/2014  More...
California Stem Cell, Inc. Announces FDA Approval Of Phase 2 Cancer Stem Cell Clinical Trial For Ovarian Cancer 2/18/2014  More...
Mast Therapeutics (MSTX) Provides Additional Results From Nonclinical Heart Failure Study 2/18/2014  More...
CytoDyn Submits Protocol To FDA For Phase 2b Clinical Study Of PRO 140 For Treatment Substitution In Patients With HIV 2/18/2014  More...
Galapagos NV (GLPG.BR) Completes Patient Recruitment In Proof Of Concept Study With GLPG0974 In Ulcerative Colitis 2/17/2014  More...
Isis Pharmaceuticals, Inc. (ISIS) Advances ISIS-SMN Rx In Infants And Children With Spinal Muscular Atrophy 2/14/2014  More...
Aerpio Initiates Phase 2 Study Of Tie2 Activator AKB-9778 For The Treatment Of Diabetic Macular Edema 2/13/2014  More...
Anacor Pharmaceuticals, Inc. (ANAC) Announces Publication Of Article Describing Boron-Containing Compounds And Their Relevance To Dermatology 2/13/2014  More...
StemCells Inc. (STEM) Announces Completion Of The First Of Two Cohorts In Its Dry Age-Related Macular Degeneration Trial 2/12/2014  More...
Generex Biotechnology Corporation (GNBT) Provides Update On Antigen Express Phase II AE37 Breast Cancer Vaccine Trial 2/12/2014  More...
Popular Weight-Lifting Supplement May Slow Huntington Disease, Massachusetts General Hospital Study 2/11/2014  More...
Alba Therapeutics Corporation Announces Positive Results Of Phase 2b Trial In Celiac Disease 2/11/2014  More...
ARIKACE To Receive Orphan Medicinal Product Designation In The European Union To Treat Lung Infections Caused By Nontuberculous Mycobacteria 2/11/2014  More...
Bionor Pharma ASA's Phase II Vacc-4x Data Published In The Lancet Infectious Diseases 2/11/2014  More...
Ultragenyx Pharmaceuticals Announces Initiation Of Phase 2 Study For Patients With Long-Chain Fatty Acid Oxidation Disorders 2/11/2014  More...
Ario Pharma Commences Phase 2a Trial Of TRPV1 Inhibitor For Cough Associated With Chronic Obstructive Pulmonary Disease 2/11/2014  More...
Addex Therapeutics (ADXN.SW)-Janssen Pharmaceutical Inc. Team's Depression Drug Fails In Phase 2a Trial 2/10/2014  More...
KaloBios Pharmaceuticals, Inc. (KBIO) Initiates Phase 2 Expansion Portion Of Study Of KB004 In Hematologic Malignancies 2/10/2014  More...
Cerulean Pharma Inc. Announces First Patient Dosed In Phase 2 Clinical Trial Of CRLX101 In Combination With Avastin® In Relapsed Ovarian Cancer 2/10/2014  More...
Targacept, Inc. (TRGT) Completes Recruitment In Phase 2b Overactive Bladder Trial Of TC-5214 2/10/2014  More...
Aduro Biotech Announces Initiation Of Phase 2b ECLIPSE Trial To Evaluate Treatment Of Patients With Pancreatic Cancer With The Company’s Innovative Immunotherapies 2/10/2014  More...
Oramed Pharmaceuticals Inc. (ORMP) Submits Phase 2a Protocol To FDA For The Treatment Of Type 1 Diabetes With Its Oral Insulin Capsule 2/10/2014  More...
AstraZeneca PLC (AZN) Takes On Merck & Co., Inc. (MRK) In Alzheimer's Drug Race 2/7/2014  More...
REGiMMUNE Begins Enrollment For Phase II Clinical Trial For Graft Versus Host Disease 2/6/2014  More...
Can-Fite BioPharma (CFBI) Submitted Phase II Study Protocol With CF102 To Treat Patients With Advanced Liver Cancer 2/6/2014  More...
Navidea Biopharmaceuticals (NAVB) Announces Positive Initial Results In Single-Center Cohort From Phase 2b Trial Of NAV4694 In Subjects With Mild Cognitive Impairment (MCI) 2/6/2014  More...
Trigemina Announces Expansion Of Phase 2 Study Of TI-001 For Chronic Migraine 2/6/2014  More...
Targovax TG01 Immunotherapy Reaches Phase 2a In Operable Pancreatic Cancer 2/6/2014  More...
Spinifex Pharmaceuticals ' Phase 2 Results Published In The Lancet Show EMA401 To Be Effective In Reducing Pain In Postherpetic Neuralgia 2/5/2014  More...
Pfizer Inc. (PFE)'s New Breast Cancer Treatment Succeeds In Phase 2 Trial 2/4/2014  More...
AEterna Zentaris (AEZS): Article On Phase 2 Results For Zoptarelin Doxorubicin In Endometrial Cancer Published In The International Journal Of Gynecological Cancer 2/4/2014  More...
FDA Grants Edison Pharmaceuticals, Inc.'s EPI-743 Orphan Status For Friedreich's Ataxia 2/4/2014  More...
Cellceutix (CTIX) Files With FDA For Phase 2b Clinical Trial Of Novel Antibiotic Brilacidin; Enrollment Of Patients Expected To Start Mid-February 2/3/2014  More...
Progenics Pharmaceuticals, Inc. (PGNX) Falls After Two Deaths In Cancer Drug Trial 1/31/2014  More...
Progenics Pharmaceuticals, Inc. (PGNX) Presents Positive Data From A Phase 2 Trial Of PSMA ADC In Patients With Chemotherapy Experienced Metastatic Castrate Resistant Prostate Cancer 1/31/2014  More...
Progenics Pharmaceuticals, Inc. (PGNX) 1404 Imaging Agent Shows High Accuracy In Detecting Cancer Within The Prostate Gland In Interim Analysis Of Phase 2 Study 1/31/2014  More...
KaloBios Pharmaceuticals, Inc. (KBIO) Pulls Plug On Asthma Drug, Shares Plunge -28.39% At Market Close (January 30, 2014) 1/30/2014  More...
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO), Astellas Pharma Inc. (ALPMY) Discontinue Phase 2 Trial Of Tivozanib In Breast Cancer 1/30/2014  More...
Cell Therapeutics, Inc. (CTIC) Announces United Kingdom National Cancer Research Institute AML Cooperative Group Phase 2 Trial Evaluating Pacritinib For Patients With Relapsed FLT3 Positive Acute Myeloid Leukemia 1/30/2014  More...
Oramed Pharmaceuticals Inc. (ORMP) Announces Successful FDA Phase 2a Clinical Trial Results 1/30/2014  More...
Galapagos NV (GLPG.BR) Release: First Clinical Centers Opened For Phase 2 Crohn's Study With GLPG0634 1/30/2014  More...
Positive Spinal Disc Repair Trial Results Using Mesoblast Limited (MSB.AX) Adult Stem Cells 1/30/2014  More...